ANTAGONISM OF NEUROLEPTICA - ANTI-PARKINSONIAN CORRECTORS

被引：0

作者：

BOURGEOIS, M ^{[1
]}

TIGNOL, J ^{[1
]}

BOUEY, P ^{[1
]}

机构：

[1] UER PSYCHIAT CTR CARREIRE,F-33076 BORDEAUX,FRANCE

来源：

NOUVELLE PRESSE MEDICALE | 1977年 / 6卷 / 07期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：564 / 564

页数：1

共 50 条

[1] ANTI-PARKINSONIAN DRUGS
BIJLSMA, UG
[J]. ACTA PHYSIOLOGICA ET PHARMACOLOGICA NEERLANDICA, 1956, 5 (01): : 107 - 107
[2] ABUSE OF ANTI-PARKINSONIAN DRUGS
CRAIG, DH
ROSEN, P
[J]. ANNALS OF EMERGENCY MEDICINE, 1981, 10 (02) : 98 - 100
[3] β-synuclein:: an anti-Parkinsonian factor?
不详
[J]. NEUROSCIENTIST, 2002, 8 (02): : 88 - 88
[4] ANTI-PARKINSONIAN DRUGS TODAY
QUINN, NP
[J]. DRUGS, 1984, 28 (03) : 236 - 262
[5] The role of new anti-Parkinsonian drugs
Bonuccelli, U
[J]. GIORNALE DI NEUROPSICOFARMACOLOGIA, 1998, 20 (02): : 39 - 41
[6] CLINICAL PHARMACOKINETICS OF ANTI-PARKINSONIAN DRUGS
CEDARBAUM, JM
[J]. CLINICAL PHARMACOKINETICS, 1987, 13 (03) : 141 - 178
[7] NEWER INDOLYL ANTI-PARKINSONIAN AGENTS
KUMAR, P
NATH, C
BHARGAVA, KP
SHANKER, K
[J]. CURRENT SCIENCE, 1983, 52 (17): : 795 - 797
[8] DOPAMINERGIC AND ANTI-PARKINSONIAN ACTIVITY OF PERGOLIDE
GOLDSTEIN, M
LIEBERMAN, A
LEW, JY
ROSENFELD, MR
MAKMAN, MH
[J]. FEDERATION PROCEEDINGS, 1980, 39 (03) : 529 - 529
[9] UTILIZATION OF ANTI-PARKINSONIAN DRUGS IN CZECHOSLOVAKIA
STIKA, L
VINAR, O
FEDERMAN, J
[J]. ACTIVITAS NERVOSA SUPERIOR, 1982, 24 (04): : 262 - 264
[10] Availability of anti-Parkinsonian drugs in Thailand
Sakdisornchai, K.
Bhidayasiri, R.
Jitkritsadakul, O.
Panyakaew, P.
Sringean, J.
[J]. MOVEMENT DISORDERS, 2017, 32